The purpose of this trial is to evaluate the effect of Avacopan treatment on renal disease activity in patients with complement component 3 glomerulopathy (C3G).
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.